Rami Makela
Turku, Finland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Ex Vivo Drug Screening Informed Targeted Therapy for Metastatic Parotid Squamous Cell Carcinoma.
Journal: Frontiers in oncology
Published: July 03, 2021
Ex vivo analysis of DNA repair targeting in extreme rare cutaneous apocrine sweat gland carcinoma.
Journal: Oncotarget
Published: July 30, 2020
Effects of Different Exercise Training Protocols on Gene Expression of Rac1 and PAK1 in Healthy Rat Fast- and Slow-Type Muscles.
Journal: Frontiers in physiology
Published: July 17, 2020
Image-based ex vivo drug screen to assess targeted therapies in recurrent thymoma.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: February 18, 2020
Ex vivo assessment of targeted therapies in a rare metastatic epithelial-myoepithelial carcinoma.
Journal: Neoplasia (New York, N.Y.)
Published: October 06, 2019
Clonal Evolution of MEK/MAPK Pathway Activating Mutations in a Metastatic Colorectal Cancer Case.
Journal: Anticancer research
Published: September 21, 2019
Ex vivo modelling of drug efficacy in a rare metastatic urachal carcinoma.
Journal: BMC cancer
Published: May 06, 2019
Systematic Identification of MicroRNAs That Impact on Proliferation of Prostate Cancer Cells and Display Changed Expression in Tumor Tissue.
Journal: European urology
Published: July 09, 2015
The HER2 amplicon includes several genes required for the growth and survival of HER2 positive breast cancer cells - A data description.
Journal: Genomics data
Published: June 10, 2014
Identifying microRNAs regulating B7-H3 in breast cancer: the clinical impact of microRNA-29c.
Journal: British journal of cancer
Published: September 17, 2013
High-throughput screens identify microRNAs essential for HER2 positive breast cancer cell growth.
Journal: Molecular oncology
Published: April 23, 2013
Last Updated: 09/26/2026